SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19Plain-Language Summary

SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19Plain-Language Summary

Rationale & Objective: A number of serologic tests for immunoglobulin G (IgG) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now commercially available, including multiple lateral flow immunoassays (LFIAs), which have the advantage of being inexpensive and easy to u...

Full description

Bibliographic Details
Main Authors: Maria Prendecki, Candice Clarke, Tom McKinnon, Liz Lightstone, Matthew C. Pickering, David C. Thomas, Stephen P. McAdoo, Michelle Willicombe
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Kidney Medicine
Subjects:
SARS-CoV-2 antibodies
COVID-19
lateral flow immunoassays (LFIAs)
hemodialysis
transplant
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059520302533

Internet

http://www.sciencedirect.com/science/article/pii/S2590059520302533

Similar Items